Skip to main content
VCbacked
Log inGet Started

Rivermark Medical

Milwaukee, United States

Rivermark Medical develops a minimally-invasive treatment for Benign Prostatic Hyperplasia (BPH) that restores urinary function.

$3.0M raised
May 2026
Series D
Health CareHospitalMedical Device

Top Investors

Andera PartnersClarevia VenturesTIME BioVenturesAmerican Century InvestmentsCadence Healthcare Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Rivermark Medical

How much funding has Rivermark Medical raised?
Rivermark Medical has raised $3.0M in total funding. The most recent round was Series D. The last funding was announced in May 2026.
Who are Rivermark Medical's investors?
Rivermark Medical's investors include Andera Partners, Clarevia Ventures, TIME BioVentures, American Century Investments, Cadence Healthcare Ventures.
Where is Rivermark Medical headquartered?
Rivermark Medical is headquartered in Milwaukee, United States.
What does Rivermark Medical do?
Rivermark Medical develops a minimally-invasive treatment for Benign Prostatic Hyperplasia (BPH) that restores urinary function.
What stage is Rivermark Medical at?
Rivermark Medical is at the Series D stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Rivermark Medical — Funding & Investors." VCBacked, May 13, 2026, https://www.vcbacked.co/company/rivermark-medical. Accessed June 17, 2026.
APA
VCBacked. (2026). Rivermark Medical — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/rivermark-medical
Wikipedia (cite web)
{{cite web |title=Rivermark Medical — Funding & Investors |url=https://www.vcbacked.co/company/rivermark-medical |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Virtuoso Surgical
Nashville
Basata
Phoenix
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Sedivention
Munich$848K